ASX Announcements

For announcements prior to 31 December 2010 please go to the ASX website and search our announcements using the ASX code EMR

March 2024 Notification regarding unquoted securities - EMR (26 March)
March 2024 Third Supplementary Target's Statement (21 March)
March 2024 Change in substantial holding (20 March)
March 2024 Third Supplementary Bidder's Statement (20 March)
March 2024 New High Grade Gold Discovery - Freeman's Find Prospect (18 March)
March 2024 Recommended and Unconditional Takeover Offer Extended (15 March)
March 2024 Application for quotation of securities - EMR (12 March)
March 2024 Option Exercise (12 March)
March 2024 Proposed issue of securities - EMR (04 March)
March 2024 Change in substantial holding (04 March)
March 2024 Notification regarding unquoted securities - EMR (04 March)
March 2024 Change in substantial holding (04 March)
March 2024 Final Director's Interest Notice (01 March)
March 2024 Board and Sub-Committee Changes (01 March)
February 2024 Emerald's Growth Strategy Underpinned by Okvau Excellence (29 February)
February 2024 Half Yearly Report and Accounts (29 February)
February 2024 Recommended and Unconditional Takeover Offer Extended (20 February)
February 2024 Second Supplementary Target's Statement (15 February)
February 2024 Application for quotation of securities - EMR (09 February)
February 2024 Option Exercise (09 February)
February 2024 Application for quotation of securities - EMR (09 February)
February 2024 Application for quotation of securities - EMR (01 February)
February 2024 Option Exercise (01 February)
January 2024 Quarterly Report (30 January)
January 2024 Recommended and Unconditional Takeover Offer Extended (25 January)
January 2024 Significant Exploration Results Continue at EMR Prospects (24 January)
January 2024 Application for quotation of securities - EMR (19 January)
January 2024 Application for quotation of securities - EMR (12 January)
January 2024 Another Impressive Quarter - Okvau Quarterly Gold Production (08 January)
January 2024 Application for quotation of securities - EMR (05 January)
December 2023 Application for quotation of securities - EMR (29 December)
December 2023 Recommended and Unconditional Takeover Offer Extended (29 December)
December 2023 Application for quotation of securities - EMR (22 December)
December 2023 Maiden Memot Gold Project Resource Statement (21 December)
December 2023 Application for quotation of securities - EMR (18 December)
December 2023 Option Exercise (18 December)
December 2023 Application for quotation of securities - EMR (18 December)
December 2023 Modern Slavery Statement (12 December)
December 2023 Application for quotation of securities - EMR (08 December)
December 2023 Change in substantial holding (07 December)
December 2023 Change of Director's Interest Notice (01 December)
December 2023 Option Exercise (01 December)
December 2023 Notification regarding unquoted securities - EMR (01 December)
December 2023 Application for quotation of securities - EMR (01 December)
December 2023 Application for quotation of securities - EMR (01 December)
November 2023 Chairman's Address - 2023 Annual General Meeting (29 November)
November 2023 Annual General Meeting Presentation (29 November)
November 2023 Results of Annual General Meeting (29 November)
November 2023 Option Exercise (24 November)
November 2023 Recommended and Unconditional Takeover Offer Extended (24 November)
November 2023 Application for quotation of securities - EMR (24 November)
November 2023 Application for quotation of securities - EMR (14 November)
November 2023 Option Exercise (14 November)
November 2023 Application for quotation of securities - EMR (13 November)
November 2023 Supplementary Target's Statement (09 November)
November 2023 Option Exercise (01 November)
November 2023 Second Supplementary Bidder's Statement (01 November)
November 2023 Application for quotation of securities - EMR (01 November)
October 2023 Quarterly Report (31 October)
October 2023 InvoCare Limited to be removed from the S&P/ASX 200 Index (31 October)
October 2023 Significant Exploration Results Continue at EMR Prospects (30 October)
October 2023 Recommended and Unconditional Takeover Offer Extended (27 October)
October 2023 Notice of Annual General Meeting/Proxy Form (26 October)
October 2023 Annual Report to shareholders (26 October)
October 2023 Letter to Shareholders - AGM Materials (26 October)
October 2023 Emerald Moves to 76.5% of Bullseye (13 October)
October 2023 Application for quotation of securities - EMR (13 October)
October 2023 Application for quotation of securities - EMR (10 October)
October 2023 Option Exercise (10 October)
October 2023 Recommended and Unconditional Takeover Offer for Bullseye (09 October)
October 2023 EMR Continues to Meet Guidance - Quarterly Gold Production (09 October)
October 2023 Recommended and Unconditional Takeover Offer Extended (06 October)
October 2023 TOV: Declaration of Unacceptable Circumstances and Orders (06 October)
October 2023 Date of Annual General Meeting (05 October)
October 2023 Proposed issue of securities - EMR (02 October)
October 2023 Notification regarding unquoted securities - EMR (02 October)
October 2023 ESOP Option Issue (02 October)